In this paper we have sought to investigate the ability to protect and restore the airway epithelial barrier function by using ACY-1083, an HDAC6 inhibitor with superior selectivity over other HDACs, in COPD preclinical model systems. The gene discussed is HDAC6; the disease is chronic obstructive pulmonary disease.